115 related articles for article (PubMed ID: 22993889)
1. [A study of adverse drug reactions in the treatment of pulmonary Mycobacterium avium complex disease].
Ichiki H; Watanabe A; Ueda S; Sato C; Abe M
Kekkaku; 2012 Jul; 87(7):487-90. PubMed ID: 22993889
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
Miwa S; Shirai M; Toyoshima M; Shirai T; Yasuda K; Yokomura K; Yamada T; Masuda M; Inui N; Chida K; Suda T; Hayakawa H
Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
[TBL] [Abstract][Full Text] [Related]
3. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
Sato K; Ebe T
Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
van Ingen J; Egelund EF; Levin A; Totten SE; Boeree MJ; Mouton JW; Aarnoutse RE; Heifets LB; Peloquin CA; Daley CL
Am J Respir Crit Care Med; 2012 Sep; 186(6):559-65. PubMed ID: 22744719
[TBL] [Abstract][Full Text] [Related]
5. [Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy-- following the guidelines for treatment].
Kobashi Y; Oka M
Kekkaku; 2008 Dec; 83(12):779-84. PubMed ID: 19172823
[TBL] [Abstract][Full Text] [Related]
6. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
[TBL] [Abstract][Full Text] [Related]
8. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Tanaka E
Kekkaku; 1996 Sep; 71(9):547-9. PubMed ID: 8999140
[No Abstract] [Full Text] [Related]
9. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koulla-Shiro S
East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
[TBL] [Abstract][Full Text] [Related]
10. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
Kuaban C; Bercion R; Koula-Shiro S
Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969
[TBL] [Abstract][Full Text] [Related]
11. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
[TBL] [Abstract][Full Text] [Related]
12. [Perspective of pulmonary MAC infection treatment].
Kurashima A
Kekkaku; 2007 Mar; 82(3):195-9. PubMed ID: 17444124
[TBL] [Abstract][Full Text] [Related]
13. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Fujita M; Kajiki A; Tao Y; Miyazaki M; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
J Infect Chemother; 2012 Apr; 18(2):146-51. PubMed ID: 21927844
[TBL] [Abstract][Full Text] [Related]
14. [Effect of combined chemotherapy following the guidelines on treatment for Mycobacterium avium complex pulmonary disease].
Kobashi Y; Okimoto N; Matsushima T; Shigetou E; Kuraoka T; Takeyama H; Eda R; Yano S; Kobayashi K; Ohnishi T; Mori K; Ueda Y; Moritaka T; Nishimura K; Abe T
Kekkaku; 2002 Jun; 77(6):435-41. PubMed ID: 12136597
[TBL] [Abstract][Full Text] [Related]
15. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Kobashi Y; Matsushima T
Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
[TBL] [Abstract][Full Text] [Related]
16. [Relations between clinical subtypes of Mycobacterium avium pulmonary disease and polyclonal infections detected by IS1245 based restriction fragment length polymorphism analysis].
Kuwabara K; Watanabe Y; Wada K; Tsuchiya T
Kekkaku; 2004 Feb; 79(2):39-46. PubMed ID: 15031998
[TBL] [Abstract][Full Text] [Related]
17. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
Ito Y; Miwa S; Shirai M; Kanai M; Fujita K; Ohba H; Iwaizumi E; Oshima T; Kojima S; Suda T; Hayakawa H
Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
[TBL] [Abstract][Full Text] [Related]
18. [Non-tuberculous mycobacteriosis. What has been coming out].
Kajiki A
Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
[TBL] [Abstract][Full Text] [Related]
19. Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system.
Ozawa T; Namkoong H; Takaya R; Takahashi Y; Fukunaga K; Enoki Y; Taguchi K; Kizu J; Matsumoto K; Hasegawa N
BMC Infect Dis; 2022 Jun; 22(1):580. PubMed ID: 35768763
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
Taki H; Ogawa K; Nakagawa T; Kashima K; Tarumi O; Saitou Y; Yamada N; Tano M; Nikai T
Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
